Skip to content
10-K

Annual Report

Whitehawk Therapeutics, Inc. WHWK

0001628280-25-015269

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 24, 2025 46.78M sh
Shares Diluted FY 2024 · Dec 31, 2023 26.92M sh
Capex FY 2024 · Dec 31, 2023 $3.97M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$59.66M
Short Term Investments FY 2024 · Dec 31, 2023 $45.96M
Cash And Equivalents FY 2024 · Dec 31, 2023 $62.89M
Current Liabilities FY 2024 · Dec 31, 2023 $26.4M
Total Liabilities FY 2024 · Dec 31, 2023 $27.23M
Current Assets FY 2024 · Dec 31, 2023 $124.59M
Total Assets FY 2024 · Dec 31, 2023 $132.42M
Eps Diluted FY 2024 · Dec 31, 2023 −$2.44
Eps Basic FY 2024 · Dec 31, 2023 −$2.44
Sga Expense FY 2024 · Dec 31, 2023 $44.55M
Rd Expense FY 2024 · Dec 31, 2023 $48.93M
Net Income FY 2024 · Dec 31, 2023 −$65.77M
Operating Income FY 2024 · Dec 31, 2023 −$71.93M
Cost Of Revenue FY 2024 · Dec 31, 2023 $2.81M
Revenue FY 2024 · Dec 31, 2023 $24.35M
Revenue FY 2024 · Dec 31, 2020 $14M
Stockholders Equity FY 2024 · Dec 31, 2022 $158.38M